Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 21, 2025; 31(23): 107100
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.107100
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.107100
Figure 5 Graphical abstract summarizing the etiology, treatments, and diagnosis of hepatocellular carcinoma in individuals without cirrhosis.
MASLD: Metabolic dysfunction-associated steatotic liver disease. Created in BioRender (Supplementary material).
- Citation: Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J. Hepatocellular carcinoma in patients without cirrhosis. World J Gastroenterol 2025; 31(23): 107100
- URL: https://www.wjgnet.com/1007-9327/full/v31/i23/107100.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i23.107100